Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Q1 2024 Revenue and Business Update
2024-04-17 15:05
TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation
2024-04-16 06:42
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain
2024-03-27 05:59
QDOSE® Platform Partnership for Personalised Dosimetry in Radiopharmaceutical Therapy
2024-03-19 05:19
Appointment of Dr Darren Patti to Group Chief Operating Officer
2024-03-12 05:44
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
2024-03-05 07:01
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
2024-02-27 05:55
Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline
2024-02-22 17:31
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
2024-02-08 06:11
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
2024-01-22 19:00
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-04 06:20
Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer
2023-12-19 05:44
First Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix's Breakthrough Kidney Cancer Imaging Agent
2023-12-11 19:40
Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS
2023-12-07 06:45
First Patient Dosed in European Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent
2023-12-04 13:00
Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS
2023-11-30 04:15
Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam®
2023-11-14 06:33
Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
2023-11-13 16:27
First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591
2023-11-13 07:38
Telix to Present at Jefferies London Healthcare Conference 2023
2023-11-09 04:51
1
2
3
4
5
6